Prebiotics in inflammatory bowel diseases

British Journal of Nutrition

Volumn 98, Issue SUPPL. 1, 2007, Pages

  Guarner, Francisco ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Animal models of IBD; Crohn's disease; Inulin; Lactulose; Microbiota; Oligofructose; Pouchitis; Ulcerative colitis

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; INULIN; MESALAZINE; PLACEBO; PREBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL GROWTH; BIFIDOBACTERIUM LONGUM INFANTIS; CLINICAL TRIAL; COLON FLORA; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CROHN DISEASE; DIET SUPPLEMENTATION; ENTERITIS; HOST RESISTANCE; HUMAN; ILEITIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION CONTROL; INFECTION PREVENTION; LACTOBACILLUS; MONOTHERAPY; MUCOSAL IMMUNITY; NONHUMAN; SYMBIOSIS; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

ANIMALIA;

EID: 35148872605     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507832958     Document Type: Conference Paper

References (38)

1. Loftus EV (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517.
2. Sawczenko A, Sandhu B, Logan R, Jenkins H, Taylor C, Mian S & Lynn R (2001) Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 357, 1093-1094.
3. Strober W, Fuss I & Mannon P (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117, 514-521.
4. García-Lafuente A, Antolín M, Guarner F, Crespo E, Salas A, Forcada P, Laguarda M, Gavaldá J, Baena JA, Vilaseca J & Malagelada JR (1997) Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 272, G10-G15.
5. Borruel N, Casellas F, Antolín M, Carol M, Llopis M, Espín E, Naval J, Guarner F & Malagelada JR (2003) Effects of non-pathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 98, 865-870.
6. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony L & Shanahan F (2006) Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118, 202-215.
7. Roberfroid MB (2005) Introducing inulin-type fructans. Br J Nutr 93, Suppl 1, S13-S25.
8. Guarner F & Malagelada JR (2003) Gut flora in health and disease. Lancet 361, 512-519.
9. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson G, Collins MD & Dore J (1999) Direct rDNA community analysis reveals a myriad of novel bacterial lineages within the human gut. Appl Environ Microbiol 65, 4.799-4.807.
10. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE & Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
11. Yamanaka T, Helgeland L, Farstad IN, Fukushima H, Midtvedt T & Brandtzaeg P (2003) Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol 170, 816-822.
12. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV & Rook GA (2006) Mechanisms of Disease: the hygiene hypothesis revisited, Nat Clin Pract Gastroenterol Hepatol 3, 275-284.
13. Cobrin GM & Abreu MT (2005) Defects in mucosal immunity leading to Crohn's disease. Immunol Rev 206, 277-295.
14. Brandtzaeg P, Carlsen HS & Halstensen TS (2006) The B-cell system in inflammatory bowel disease. Adv Exp Med Biol 579, 149-167.
15. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J & Bjamason I (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38, 365-375.
16. Guarner F (2005) The intestinal flora in inflammatory bowel disease: normal or abnormal? Curr Opin Gastroenterol 21, 414-418.
17. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, Marteau P & Dore J (2006) Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12, 106-111.
18. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux & Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J & Dore J (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211.
19. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UP, Timmis KN & Schreiber S (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693.
20. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V. Ortner M, Weber J, Hoffmann U, Schreiber S. Dietel M & Lochs H (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44-54.
21. Kleessen B, Kroesen AJ, Buhr HJ & Blaut M (2002) Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 37, 1034-1041.
22. Macfarlane S, Furrie E, Cummings JH & Macfarlane GT (2004) Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38 1690-1699.
23. Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S & Watzl B (2004) PASS-CLAIM-gut health and immunity. Eur J Nutr 43, Suppl 2, 118-173.
24. Gibson GF, Probert HM, Van Loo J, Rastall RA & Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr Res Rev 17, 259-275.
25. Macfarlane S, Macfarlane GT & Cummings JH (2006) Review Article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther. 24, 701-714.
26. Langlands SJ, Hopkins MJ, Coleman N Cummings JH (2004) Prebiotic caibohydrates modify the mucosa-associated microflora of the human large bowel. Gut 53, 1610-1616.
27. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA & Macfarlane GT (2005) Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulberative colitis: A randomized controlled pilot trial. Gut 54 242-249.
28. Videla S, Vilaseca J, Antolín M, García-tafuente A, Guarner F, Crespo E, Casalots J, Salas A & Malagelada JR (2001) Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 96, 1486-1493.
29. Lugea A, Salas A, Casalot J, Guarner F & Malagelada JR (2000) Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins. Gut 46, 515-521.
30. Osman N, Adawi D, Molin G, Ahrne S, Berggren A & Jeppsson B (2006) Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol 6, 31.
31. Cherbut C, Michel C & Lecannu G (2003) The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133, 21-27.
32. Hoentjen F, Welling GW, Harmsen HJM, Zhang XY, Snart J, Tannock GW, Lien K, Churchill TA, Lupicki M & Diele an LA (2005) Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis 11, 977-985.
33. Madsen KL, Doyle JS, Jewell LD, Tavernini MM & Fedorak RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107-1114.
34. Rumi G, Tsubouchi R, Okayama M, Kato S, Mozsik G & Takeuchi K (2004) Protective effect of lactulose on dextran sulphate sodium-induced colonic inflammation in rats. Dig Dis Sci 49, 1466-1472.
35. Camuesco D, Peran L, Comalada M, Nieto A, Di Stasi LC, Rodriguez-Cabezas ME, Concha A, Zarzuelo A & Galvez J (2005) Preventative effects of lactulose in the trinitrobenzene-sulphonic acid model of rat colitis. Inflamm Bowel Dis 11, 265-271.
36. Welters CFM, Heineman E, Thunnissen BJM, van den Bogaard AEJM, Soeters PB & Baeten CGMI (2002) Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum 45, 621-627.
37. Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F & Malagelada JR (2007) Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 25, 1061-1067.
38. Lindsay JO, Whelan Y, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm MA, Knight SC & Forbes A (2006) Clinical, microbiological, and immunological effects of fructooligosaccharide in patients with Crohn's disease. Gut 55, 348-355.